Please provide your email address to receive an email when new articles are posted on . Urate-lowering treatment reduced the 5-year risk for major adverse cardiovascular events for patients with gout.

Gout, a type of inflammatory arthritis caused by a buildup of uric acid (urate) in the body, affects 5.1% of U.S. adults (over 12 million), including 10% of those aged 65 or older. Urate is produced ...

Dear Dr. Roach: I am a regular blood donor. In the 7-10 days before a donation, I take iron supplements to ensure that my hemoglobin count is sufficient enough to give blood. However, I now think that ...

A groundbreaking new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout. The new ...

Gout is becoming a younger man’s disease. Gout medications like allopurinol reduce heart attack and stroke risks, new study finds. “This is the first study to find that medicines such as allopurinol..

A new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout. The new research, ...

A new study finds that TikTok videos about gout frequently spread confusing or inaccurate advice. Most clips focus on diet changes and supplements, while barely mentioning the long-term treatments ...

Racial disparities in gout and gout treatment are an ongoing but tractable problem, research at the 2025 American College of Rheumatology (ACR)'s annual meeting suggested. In a 10-year ...

The mayo dump on the winning coach of the Duke's Mayo Bowl has turned into a bowl season tradition. When the five-gallon cooler of Duke’s Mayo flows over the winning coach of the Duke’s Mayo Bowl on ...

Fresh off a $153 million series E round, Arthrosi Therapeutics is skipping an IPO route and is instead being bought up for a potential value of $1.5 billion from Swedish biopharma Sobi. Under the deal ...

Among patients with gouty arthritis initiating urate-lowering therapy, a single subcutaneous injection of firsekibart — an interleukin-1 beta antibody — reduced acute flares more than a daily dose of ...

Osteoporosis may be under-recognized and inadequately managed in gout patients, new research presented at the American College of Rheumatology (ACR) annual meeting suggested. Compared with ...